K904310

Substantially Equivalent

RHEUMAGEN RF T-CONTROL

Applicant: Biokit USA, Inc.
Product code: DHR
Advisory panel: Immunology
Date received: 1990-09-19
Decision date: 1991-05-31
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Barcelona, ES

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.